Outcome of Patients with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) Treated with Ibrutinib within a Named Patient Program (NPP) in Italy. a Real-Life Retrospective Study
Abstract
Data di Pubblicazione:
2018
Tipologia CRIS:
04E-Meeting abstract in rivista
Elenco autori:
Mauro, FR; Soddu, S; Frustaci, AM; Orsucci, L; Motta, M; Scarfo, L; Zinzani, PL; Falzetti, F; Farina, L; Marasca, R; Cortelezzi, A; Carlo-Stella, C; Molica, S; Coscia, M; Zaja, F; Laurenti, L; de Fabritiis, P; Gaidano, G; Gobbi, M; Tani, M; Di Renzo, N; Fazi, P; Vignetti, M; Cuneo, A; Foa, R
Link alla scheda completa:
Pubblicato in: